News

A Canadian study has exciting findings about offspring exposed to tumor necrosis factors.

Legislation removes FDA involvement when patients seek experimental medications. Here’s what critics and proponents say.

Experts say Anthem’s acquisition of Aspire Health, the nation’s biggest non-hospice, community-based palliative care provider, continues the health insurer race to dominate this kind of health experience.

In a decision reached through the joint FDA/CMS Parallel Review process, CMS has granted national Medicare coverage to next-generation sequencing tests approved or cleared by the FDA as companion diagnostics for cancer therapies. This is clearly a win for Medicare beneficiaries and some NGS test providers-but is it also good news for MCOs?

A network of value-based care programs from the Blue Cross Blue Shield Association emphasizes quality instead of quantity of medical services provided.

Major depression diagnoses have risen, according to a study of medical claims by the Blue Cross Blue Shield Association. Find out which populations suffer the most.

For far too long, chart chasing was the best method health plans had to improve HEDIS® measures and Medicare Star ratings. Now, there is a better way.

We’ve detailed 10 proven ways all health plans can put into practice now to improve scores this HEDIS® season.

Have two minutes? Listen to this quick podcast for critical takeaways from three of our top articles.

Healthcare organizations should focus on these things to improve health management of COPD patients and reduce costs.

FDA is asking manufacturers to immediately stop selling OTC products containing the pain reliever benzocaine (such as Orajel) for teething in infants or children.

While the pharmaceutical industry has made tremendous advances in new drug development this year, FDA has also had to remove drugs from the market or investigate problem drugs. Here are the top 3 drug warnings and problems so far in 2018.

Two studies from the University of Minnesota’s School of Public Health has interesting findings about primary care among low-income patients enrolled in a Medicaid ACO.

Two experts highlight noteworthy updates in the transplant and cellular therapy space. Read more.

The Center for Blood and Cancer Disorders in Fort Worth, Texas, is participating in many value-based contracts. Here’s how it is successful.

A new study explored racial/ethnic differences in healthcare outcomes among patients receiving home healthcare. Here are the shocking results.

Congress recently began hearings on proposals to combat opioid abuse. Our policy analyst weighs in.

Here's how artificial intelligence improves the healthcare ecosystem.

Experts say this new migraine medication, the first in 50 years, shows great promise. Here’s what you need to know, including the cost implications

A new survey from Express Scripts has surprisingly findings about medication adherence in patients with chronic diseases.

A new study sheds light on PDMPs and their effectiveness in tackling the opioid crisis and includes one disturbing finding you won’t believe.

Jill Feldstein, MPA, chief operating officer for the Penn Center for Community Health Workers, tells Managed Healthcare Executive how the organization improves population health and provides social support, advocacy, and navigation to high-risk patients.

A new survey by Black Book Research found the top requested services from patients are available through EHRs.

A new study says that physicians and nurses might be overlooking these alerts-a move that risks putting patients in danger.